A weekly summary of Novamind news and media
FEATURES March 2, 2021
Dr. Reid Robison on Novamind’s Innovative Approach to Psychedelic Medicine
Novamind’s Chief Medical Officer discusses the growing need for breakthrough mental health treatments and how Novamind is helping to bring psychedelic medicine into everyday healthcare.
Novamind Expands Leadership Team, Accelerating M&A
March 3, 2021
Novamind Reports Company Highlights and Strong Revenue Growth in Fiscal Second Quarter
March 1, 2021
Follow @novamind_inc on Instagram
Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly-owned subsidiaries of Novamind. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit novamind.ca
Tags: COMPASS PATHWAYS, CSE, Field Trip Health Ltd., MIND MEDICINE (MINDMED) INC, NUMINUS WELLNESS INC